STVN Stevanato Group S.p.A.

NYSE stevanatogroup.com


$ 26.00 $ 0.00 (0 %)    

Thursday, 06-Nov-2025 06:30:00 EST
QQQ $ 623.98 $ 0.00 (0 %)
DIA $ 473.14 $ 0.00 (0 %)
SPY $ 678.41 $ 0.00 (0 %)
TLT $ 89.15 $ 0.00 (0 %)
GLD $ 369.22 $ 0.00 (0 %)
$ 25
$ 25.01
$ 25.40 x 6
$ 27.58 x 9
-- - --
$ 17.44 - $ 28.00
405,220
na
7.57B
$ 0.79
$ 62.10
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stevanato-group-raises-fy2025-gaap-eps-guidance-from-054-059-to-056-061-vs-061-est

Stevanato Group (NYSE:STVN) raises FY2025 GAAP EPS guidance from $0.54-$0.59 to $0.56-$0.61 vs $0.61 analyst estimate..

 stevanato-group-raises-fy2025-adj-eps-guidance-from-053-057-to-058-063-vs-061-est-raises-fy2025-sales-guidance-from-1238b-1270b-to-1391b-vs-1360b-est

Stevanato Group (NYSE:STVN) raises FY2025 Adj EPS guidance from $0.53-$0.57 to $0.58-$0.63 vs $0.61 analyst estimate. Raises FY...

 stevanato-gr-q3-adj-eps-016-beats-014-estimate-sales-354507m-beat-335830m-estimate

Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 1...

 stevanato-group-expands-german-facility-to-boost-drug-delivery-device-production-and-strengthen-global-pharma-supply-chain

Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to th...

 stevanato-group-raises-fy2025-gaap-eps-guidance-from-049-054-to-054-059-vs-052-est

Stevanato Group (NYSE:STVN) raises FY2025 GAAP EPS guidance from $0.49-$0.54 to $0.54-$0.59 vs $0.52 analyst estimate..

 stevanato-group-affirms-fy2025-adj-eps-guidance-of-053-057-vs-053-est-affirms-fy2025-sales-guidance-of-1238b-1270b-vs-1177b-est

Stevanato Group (NYSE:STVN) affirms FY2025 Adj EPS guidance from $0.53-$0.57 to $0.53-$0.57 vs $0.53 analyst estimate. Affirms ...

 stevanato-gr-q2-adj-eps-013-beats-010-estimate-sales-317465m-beat-268596m-estimate

Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 2...

 stevanato-secures-200m-from-top-lenders-expands-biologics-capacity-in-indiana-and-italy-to-meet-soaring-demand

Stevanato Group S.p.A. (NYSE:STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharm...

 stevanato-group-continues-to-expect-revenue-in-the-range-of-1160-million-to-1190-million-for-fy-2025-adjusted-diluted-eps-in-the-range-of-050-to-054

Stevanato Group (NYSE:STVN) continues to expect revenue in the range of €1,160 million to €1,190 million for FY 2025. Adjusted ...

 stevanato-gr-q1-adj-eps-us011-inline-sales-us26984m-up-from-us25631m-yoy

Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.11 per share which met the analyst consensus estimate. This is a 22....

 ubs-maintains-neutral-on-stevanato-group-lowers-price-target-to-235

UBS analyst John Sourbeer maintains Stevanato Group (NYSE:STVN) with a Neutral and lowers the price target from $24 to $23.5.

 stevanato-expects-2025-sales-of-116b-119b-versus-consensus-of-1175b-with-adjusted-eps-of-051-055-versus-consensus-of-054-and-adjusted-ebitda-of-293m-3063m

2025 GuidanceThe Company is introducing full year 2025 guidance and expects:Revenue in the range of €1,160 million to €1,190 mi...

 stevanato-gr-q4-2024-adj-eps-019-beats-018-estimate-sales-33060m-beat-32210m-estimate

Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.18 by 5...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION